Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Brain Neoplasms × Panobinostat × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 11 Recurrence 7 Lymphoma, Large B-Cell, Diffuse 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia 3 Waldenstrom Macroglobulinemia 2 Neoplasms 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Extranodal NK-T-Cell 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Immunoblastic Lymphadenopathy 2 Hodgkin Disease 2 Colorectal Neoplasms 2 Thyroid Neoplasms 1 Thyroid Diseases 1 Stomach Neoplasms 1 Somatostatinoma 1 Small Cell Lung Carcinoma 1 Sezary Syndrome 1 Sarcoma 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Plasmacytoma 1 Pancreatic Neoplasms 1 Oligodendroglioma 1

Interventions

Temozolomide 61 Bevacizumab 52 Radiotherapy 35 Radiosurgery 26 Carboplatin 21 pembrolizumab 15 Etoposide 15 Nivolumab 14 Irinotecan 14 Cisplatin 13 Carmustine 13 Magnetic Resonance Spectroscopy 12 Ipilimumab 12 Erlotinib Hydrochloride 12 Cyclophosphamide 12 Pemetrexed 11 Surgical Procedures, Operative 10 Topotecan 9 Lapatinib 9 Capecitabine 9 Thalidomide 8 Aminolevulinic Acid 8 Lomustine 7 Imatinib Mesylate 7 Gefitinib 7 Filgrastim 7 trametinib 6 osimertinib 6 encorafenib 6 cabozantinib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04897880 2025-02-24

NORTH

Australian & New Zealand Children's Haematology/Oncology Group

Phase 2 Terminated

Brain Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡